HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Walther Selected Research

WL 19

10/2013A small molecule angiotensin II type 2 receptor (ATâ‚‚R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Walther Research Topics

Disease

47Aortic Valve Stenosis (Aortic Stenosis)
02/2022 - 09/2002
18Stroke (Strokes)
01/2022 - 02/2002
14Heart Failure
10/2020 - 06/2004
14Myocardial Infarction
10/2017 - 08/2002
11Chagas Disease (American Trypanosomiasis)
01/2021 - 05/2003
11Hypertension (High Blood Pressure)
10/2016 - 06/2002
11Atrial Fibrillation
01/2016 - 09/2003
9Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2021 - 06/2004
9Coronary Artery Disease (Coronary Atherosclerosis)
10/2020 - 07/2006
9Fibrosis (Cirrhosis)
12/2019 - 11/2003
8Cardiovascular Diseases (Cardiovascular Disease)
12/2019 - 01/2007
6Inflammation (Inflammations)
05/2019 - 06/2005
6Pathologic Constriction (Stenosis)
07/2018 - 05/2002
6Pre-Eclampsia (Preeclampsia)
02/2013 - 12/2005
6Cardiogenic Shock
02/2010 - 11/2003
5Renal Insufficiency (Renal Failure)
04/2015 - 04/2004
5Diabetic Cardiomyopathies
06/2009 - 12/2002
4Bicuspid Aortic Valve Disease
02/2021 - 06/2019
4Obesity
05/2020 - 04/2002
4Frailty
01/2020 - 01/2011
4Hemorrhage
01/2019 - 03/2005
4Aortic Valve Disease
01/2018 - 06/2009
4Heart Arrest (Cardiac Arrest)
11/2016 - 07/2006
4Ischemia
05/2016 - 12/2002
4Low Cardiac Output
05/2015 - 01/2004
4Cardiomyopathies (Cardiomyopathy)
01/2014 - 12/2002
4Peripheral Vascular Diseases (Peripheral Vascular Disease)
03/2013 - 02/2003
4Body Weight (Weight, Body)
03/2011 - 04/2002
4Diabetes Mellitus
08/2008 - 12/2002
3Aortic Dissection
01/2022 - 10/2003
3Neoplasms (Cancer)
01/2021 - 08/2005
3Infections
10/2020 - 02/2003
3Portal Hypertension
05/2020 - 01/2015
3Endocarditis
11/2019 - 07/2011
3Rupture
01/2018 - 05/2006
3Acute Lung Injury
12/2016 - 11/2013
3Death (Near-Death Experience)
01/2015 - 06/2009
3Cardiomegaly (Heart Hypertrophy)
03/2010 - 06/2007
3Hyperglycemia
06/2009 - 12/2002
2Mitral Valve Insufficiency (Mitral Regurgitation)
01/2022 - 07/2017
2Wounds and Injuries (Trauma)
10/2021 - 05/2016
2Suppuration
10/2021 - 01/2020
2Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2021
2Chronic Renal Insufficiency
01/2021 - 06/2011
2Hypothermia
10/2020 - 04/2008
2Liver Cirrhosis (Hepatic Cirrhosis)
05/2020 - 01/2015
2Non-alcoholic Fatty Liver Disease
05/2020 - 12/2019
2Liver Diseases (Liver Disease)
01/2020 - 04/2015

Drug/Important Bio-Agent (IBA)

12angiotensin I (1-7)IBA
03/2022 - 08/2008
9Angiotensin IIIBA
10/2017 - 02/2002
8AngiotensinsIBA
03/2021 - 06/2004
7Angiotensin Receptors (Angiotensin II Receptor)IBA
10/2016 - 02/2002
6Brain Natriuretic Peptide (Natrecor)FDA Link
01/2015 - 05/2003
6Messenger RNA (mRNA)IBA
10/2013 - 12/2002
6Streptozocin (Streptozotocin)FDA Link
06/2009 - 05/2004
5Proteins (Proteins, Gene)FDA Link
11/2018 - 09/2006
5AutoantibodiesIBA
02/2013 - 12/2005
5C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA
01/2010 - 01/2002
5Atrial Natriuretic Factor (ANF)IBA
01/2010 - 12/2006
4CytokinesIBA
01/2021 - 12/2005
4EnzymesIBA
05/2019 - 09/2010
4Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
05/2019 - 02/2010
4Peptides (Polypeptides)IBA
10/2017 - 06/2004
4Dental Porcelain (Porcelain)IBA
04/2015 - 08/2010
4Natriuretic PeptidesIBA
01/2010 - 12/2006
3Biological ProductsIBA
01/2022 - 05/2014
3ReninIBA
05/2020 - 01/2007
3AVE 0991IBA
12/2019 - 08/2008
3Biomarkers (Surrogate Marker)IBA
05/2019 - 01/2015
3Angiotensin-Converting Enzyme 2IBA
12/2016 - 02/2010
3Neprilysin (Neutral Endopeptidase)IBA
01/2016 - 08/2002
3Type 2 Angiotensin ReceptorIBA
10/2013 - 01/2005
3Lactic Acid (Lactate)FDA LinkGeneric
02/2010 - 06/2005
3CollagenIBA
09/2009 - 09/2006
3AngiotensinogenIBA
01/2009 - 02/2002
3BradykininIBA
11/2006 - 08/2002
3ArgonIBA
05/2005 - 11/2003
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
03/2021 - 01/2009
2Tyrosine Kinase InhibitorsIBA
01/2021 - 01/2021
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021 - 01/2021

Therapy/Procedure

47Transcatheter Aortic Valve Replacement
01/2022 - 03/2008
22Therapeutics
01/2022 - 04/2002
13Prostheses and Implants (Prosthesis)
01/2022 - 05/2002
13Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2020 - 04/2002
11Length of Stay
02/2022 - 10/2002
10Cardiopulmonary Bypass (Heart-Lung Bypass)
11/2022 - 10/2003
8Sternotomy
10/2021 - 04/2002
6Bioprosthesis
11/2019 - 06/2009
5Extracorporeal Membrane Oxygenation
11/2016 - 11/2003
5Catheters
06/2014 - 05/2006
4Stents
01/2022 - 08/2009
3Surgical Instruments (Clip)
10/2021 - 07/2014
3Ligation
01/2015 - 06/2007
3Transplantation
11/2013 - 01/2005
3Contraindications
08/2008 - 06/2008
3Cryosurgery
10/2005 - 11/2003
3Hemofiltration
04/2004 - 02/2003
2Renal Replacement Therapy (Therapies, Renal Replacement)
11/2020 - 04/2004
2Arterial Switch Operation
10/2020 - 04/2008
2Chest Tubes (Chest Tube)
01/2020 - 04/2008